Katrin Sangkuhl
Stanford University(US)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Genomics and Rare Diseases, Pharmaceutical studies and practices, Genetic Associations and Epidemiology, Receptor Mechanisms and Signaling
Most-Cited Works
- → Pharmacogenomics Knowledge for Personalized Medicine(2012)1,837 cited
- → Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors(2015)958 cited
- → Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update(2013)952 cited
- → An Evidence‐Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine(2021)742 cited
- → Clinical assessment incorporating a personal genome(2010)676 cited
- → Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update(2016)651 cited
- → Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group(2019)507 cited
- → Prediction of CYP2D6 phenotype from genotype across world populations(2016)505 cited
- → Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy(2011)481 cited
- → Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants(2013)452 cited